TP53 mutations in epithelial ovarian cancerYu Zhang, Hua Lu, Lan Cao et al.|Translational Cancer Research|2016Cited by 149
A Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with <i>FLT3</i>-Mutated Acute Myeloid Leukemia: Results from a Phase I/II StudyNicholas J. Short, Farhad Ravandi, Hagop M. Kantarjian et al.|Blood|2021Cited by 36
Abstract 6372: Nanodrug delivery system for non-genotoxic p53 activator INZ-CNimisha Bhattarai, Hua Lu, Li Li et al.|Cancer Research|2022Cited by 0